BioIQ Scores Venture Capital

At-Home Diagnostics for Individuals and Companies

Santa Barbara-based BioIQ announced that it secured $2.5 million in growth capital (Series B financing) primarily through the venture firm Great Pacific Capital, whose managing partner, Dave Gross, will now take a seat on the company’s board. BioIQ produces biometric tools that allow individuals to self-screen for chronic conditions including diabetes, cancer, and heart disease. The in-home consumer-friendly kits’ major market currently is corporate: Employees submit information anonymously to their employer, who can then tailor health plans employees’ needs. More kits may also be marketed in the future directly to consumers. Among other benefits, this would allow people to detect conditions—even before they experience symptoms—without creating a record that might disqualify them from obtaining health insurance.

To submit a comment on this article, email or visit our Facebook page. To submit information to a reporter, email

Be succinct, constructive, and relevant to the story. Leaving a comment means you agree to our Discussion Guidelines. We like civilized discourse. We don't like spam, lying, profanity, harassment or personal attacks.

comments powered by Disqus
event calendar sponsored by:

Santa Barbara Rental Prices Have Skyrocketed Over the Last Five Years

The average rent for a South Coast studio is $1,553.

Trio Stops the Show at Board of Education

More than a dozen appeal to Santa Barbara Unified School District to maintain music classes and programs.

Santa Barbara District Attorney Endorses Villaraigosa for Governor

Joyce Dudley preferred the former Los Angeles mayor’s positions on crime and education.

San Marcos Principal Files Suit Against Santa Barbara Unified School District

Ed Behrens charges emotional and physical distress due to demotion.

City Water Use Hits 1958 Levels

Population was twice today's; revenue close to falling short of expenses.